Funding Atlas programme

High Risk/High Gain Cancers de mauvais pronostic

Institut national du cancer (INCa)

JurisdictionFranceFunding typeGrant

Documented facts

Key facts

Funder: Institut national du cancer (INCa)
Jurisdiction: France
Record type: Opportunity
Funding type: Grant
Amount: EUR 250,000
Next deadline: 15 December 2026

Published rule provenance

Eligibility information

Country / jurisdiction: Encoded condition recorded; read its source quotation.
Eligibility rule, quoted from the funder
Il doit être rattaché à un organisme éligible défini au § 3.3 et travailler en France ;
Quoted source
Organisation type: Rule not encoded
Company size: Rule not encoded
Stage: Rule not encoded
Therapeutic area: Rule not encoded
Amount sought: Rule not encoded

Further quoted conditions

Eligibility rule, quoted from the funder: amount_requested

Coordonnateur titulaire : 125 K€ maximum

Quoted source

Eligibility rule, quoted from the funder: amount_requested

Coordonnateur contractuel : 250 K€ maximum (125K€ + salaire du porteur plafonné à 125K€)

Quoted source

Eligibility rule, quoted from the funder: area

Ces cancers, dits de mauvais pronostic, sont définis par une survie nette à 5 ans inférieure à 33%, tous stades confondus.

Quoted source

Eligibility rule, quoted from the funder: entity

Organismes publics de recherche (universités, établissements publics à caractère scientifique et technologique (EPST), établissements publics à caractère industriel et commercial (EPIC), …) ;

Quoted source

Eligibility rule, quoted from the funder: entity

Établissements de santé (centres hospitaliers et universitaires (CHU), centres de lutte contre le cancer (CLCC), centres hospitaliers (CH), privés à but lucratif ou non).

Quoted source

Site note: This record is not advice or a funder decision.